Sermorelin
A synthetic fragment of growth-hormone-releasing hormone (GHRH) that acts on the pituitary gland.
What this compound is.
Sermorelin corresponds to the first 29 amino acids of growth-hormone-releasing hormone (GHRH) — the signal the hypothalamus uses to prompt the pituitary gland. Rather than introducing growth hormone directly, it acts one step upstream, on the gland that produces it.
Because it works through the body's own regulatory pathway, the pituitary's normal feedback controls remain in the loop. That mechanism is why it has been a long-standing subject of endocrine research rather than a shortcut around the body's signaling.
How it has been studied.
Neutral notes on how this compound has been studied. These are not claims of safety or effectiveness, and not medical advice.
Studied in the clinical context of age-related decline in the body's endogenous growth-hormone secretion.
Investigated historically as a diagnostic aid for evaluating pituitary function.
Examined in research on the growth-hormone axis and its relationship to body composition and recovery.
Format, and what a provider weighs.
Prescribed formulations are typically administered by subcutaneous injection. Form and suitability are a provider's decision — nothing here is a recommendation, a protocol, or a dose.
- A provider reviews your history for endocrine conditions, current medications, and contraindications before considering any prescription.
- Not appropriate during pregnancy or while breastfeeding.
- Whether treatment is offered — and in what form — is a provider's decision, and availability varies by state.
Sermorelin cannot be purchased directly on this site. It is available only after a licensed provider evaluates your intake and determines that treatment is clinically appropriate, and it is dispensed by a licensed compounding pharmacy. Eligibility is never guaranteed, and availability varies by state. See how it works and our approach to care.